Related Experiment Video
Updated: Jun 20, 2025

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
[Research Progress on Pathogenesis and Treatment of NUT Carcinoma]
1Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin 300060, China.
Abstract:
NUT carcinoma (nuclear protein in testis carcinoma) is a rare and highly invasive malignant tumor, which is most common in midline organs and lungs. The characteristic genetic change of NUT carcinoma is the rearrangement of NUT middle carcinoma family member 1 (NUTM1) gene. In this article, we will review the pathogenic mechanism of its most common fusion form, bromodomaincontaining protein 4 (BRD4)-NUTM1 fusion gene, and the progress in the research and development of targeting drugs. .
Insights
NUT carcinoma is a rare, aggressive cancer primarily affecting midline organs and lungs. This review covers the BRD4-NUTM1 fusion gene
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- NUT carcinoma is a rare, highly invasive malignancy.
- It predominantly affects midline organs and the lungs.
- A key genetic hallmark is the NUTM1 gene rearrangement.
Purpose of the Study:
- To review the pathogenic mechanisms of the common BRD4-NUTM1 fusion gene.
- To discuss advancements in targeted drug development for NUT carcinoma.
Main Methods:
- Literature review of pathogenic mechanisms.
- Review of current targeted therapy research.
Main Results:
- The BRD4-NUTM1 fusion drives oncogenesis through specific molecular pathways.
- Several targeted therapies are under investigation, showing promising preclinical and early clinical results.
Conclusions:
- Understanding the BRD4-NUTM1 fusion is crucial for effective treatment strategies.
- Targeted therapies represent a promising avenue for managing this aggressive cancer.
Related Concept Videos
Cancer Prevention
Some...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against...

